TerrAscend (TSNDF) Return on Capital Employed (2022 - 2026)
TerrAscend's (TSNDF) quarterly Return on Capital Employed came in at 8.51% in Q1 2026, up 57.0% year-on-year from 5.42% in Q1 2025, and down 3.57% on a QoQ basis from 8.82% in Q4 2025.
TerrAscend (TSNDF) Return on Capital Employed (2022 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 5 years of Return on Capital Employed data on file, last reported at 8.51% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 57.0% year-over-year to 8.51% in Q1 2026; TTM through Mar 2026 was 8.51%, a 57.0% increase from a year earlier, with the FY2025 full-year figure at 8.36%, up 123.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 8.51%, down from 8.82% in the prior quarter.
- Over the last five years, Return on Capital Employed for TSNDF reached as high as 17.54% in Q3 2023 and fell as low as 142.21% in Q2 2023.
- Historically, Return on Capital Employed has averaged 12.76% across 5 years, with a median of 6.59% in 2024.
- Across the five-year window, Return on Capital Employed sank 14075 bps in 2023 and soared 14895 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 58.36% in 2022, then soared by 110 bps to 6.02% in 2023, then increased by 9 bps to 6.59% in 2024, then jumped by 34 bps to 8.82% in 2025, then fell by 4 bps to 8.51% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 8.51% in Q1 2026, 8.82% in Q4 2025, and 9.44% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 8.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.51% |
| Dec 31, 2025 | 8.82% |
| Sep 30, 2025 | 9.44% |
| Jun 30, 2025 | 8.52% |
| Mar 31, 2025 | 7.94% |
| Dec 31, 2024 | 6.59% |
| Sep 30, 2024 | 4.94% |
| Jun 30, 2024 | 6.74% |
| Mar 31, 2024 | 6.93% |
| Dec 31, 2023 | 6.02% |
| Sep 30, 2023 | 17.54% |
| Jun 30, 2023 | -142.21% |
| Mar 31, 2023 | -59.42% |
| Dec 31, 2022 | -58.36% |
| Sep 30, 2022 | -49.12% |
| Jun 30, 2022 | -1.46% |
| Mar 31, 2022 | 1.65% |